Adherence to extended postpartum antiretrovirals is associated with decreased breast milk HIV-1 transmission
- PMID: 25493600
 - PMCID: PMC4397579
 - DOI: 10.1097/QAD.0000000000000492
 
Adherence to extended postpartum antiretrovirals is associated with decreased breast milk HIV-1 transmission
Abstract
Objective: Estimate association between postpartum antiretroviral adherence and breast milk HIV-1 transmission.
Design: Prospective cohort study.
Methods: Mother-infant pairs were randomized after delivery to immediately begin receiving 28 weeks of either triple maternal antiretrovirals (zidovudine, lamivudine, and either nevirapine, nelfinavir, or lopinavir-ritonavir) or daily infant nevirapine as part of the Breastfeeding, Antiretrovirals, and Nutrition (BAN) study. Associations between postpartum antiretroviral adherence and rate of breast milk HIV-1 transmission were estimated using Cox models. We measured adherence over four postpartum time intervals using pill count, suspension bottle weight, and maternal self-report. Adherence was categorized and lagged by one interval. Missing adherence measures were multiply imputed. Infant HIV-1 infection was determined by DNA PCR every 2-6 weeks. The primary endpoint was infant HIV-1 infection by 38 weeks of age among infants alive and uninfected at 5 weeks.
Results: Analyses included 1479 mother-infant pairs and 45 transmission events. Using pill count and bottle weight information, 22-40% of mother-infant pairs at any given interval were less than 90% adherent. Having at least 90% adherence was associated with a 52% [95% confidence interval (CI) 3-76] relative reduction in the rate of breast milk HIV-1 transmission, compared with having less than 90% adherence when controlling for study arm, breastfeeding status, and maternal characteristics. Complete case analysis rendered similar results (n = 501; relative reduction 59%, 95% CI 6-82).
Conclusion: Nonadherence to extended postpartum antiretroviral regimens in 'real world' settings is likely to be higher than that seen in BAN. Identifying mothers with difficulty adhering to antiretrovirals, and developing effective adherence interventions, will help maximize benefits of antiretroviral provision throughout breastfeeding.
References
- 
    
- World Health Organization Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2013 - PubMed
 
 - 
    
- World Health Organization Programmatic Update: Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Executive summary. 2012
 
 - 
    
- Barigye H, Levin J, Maher D, Tindiwegi G, Atuhumuza E, Nakibinge S, et al. Operational evaluation of a service for prevention of mother-to-child transmission of HIV in rural Uganda: barriers to uptake of single-dose nevirapine and the role of birth reporting. Trop Med Int Health. 2010;15:1163–1171. - PubMed
 
 - 
    
- Peltzer K, Mlambo M, Phaswana-Mafuya N, Ladzani R. Determinants of adherence to a single-dose nevirapine regimen for the prevention of mother-to-child HIV transmission in Gert Sibande district in South Africa. Acta Paediatr. 2010;99:699–704. - PubMed
 
 - 
    
- Peltzer K, Sikwane E, Majaja M. Factors associated with short-course antiretroviral prophylaxis (dual therapy) adherence for PMTCT in Nkangala district, South Africa. Acta Paediatr. 2011;100:1253–1257. - PubMed
 
 
Publication types
MeSH terms
Substances
Grants and funding
- D43 TW001039/TW/FIC NIH HHS/United States
 - U48-CCU409660-09/PHS HHS/United States
 - U48-DP000059-01/DP/NCCDPHP CDC HHS/United States
 - U48DP001944/ACL/ACL HHS/United States
 - R24 TW007988/TW/FIC NIH HHS/United States
 
- P30-AI50410/AI/NIAID NIH HHS/United States
 - 5T32AI070114/AI/NIAID NIH HHS/United States
 - U48-DP001944-01/DP/NCCDPHP CDC HHS/United States
 - T32 AI070114/AI/NIAID NIH HHS/United States
 - U48 DP000059/DP/NCCDPHP CDC HHS/United States
 - 2-D43 TW01039-06/TW/FIC NIH HHS/United States
 - P30 AI050410/AI/NIAID NIH HHS/United States
 
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
              